Bicara Therapeutics Financial Statements 2023-2025 | BCAX

Fifteen years of historical annual and quarterly income statements for Bicara Therapeutics (BCAX).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM20242023
$0.00$0$0
$0.00$0$0
$0.00$0$0
$62.23$63.62$30.62
$15.56$18.77$9.27
$0.00$0$0
$0.00$0$0
$-77.79$-82.39$-39.89
$11.03$14.58$-12.09
$-66.76$-67.81$-51.98
$0.07$0.19$0.01
$-66.84$-68.00$-51.99
$0.00$0$0
$-66.84$-68.00$-51.99
$0.00$0$0
$-66.84$-68.00$-51.99
$-77.76$-82.33$-39.87
$-77.79$-82.39$-39.89
$-21.22$-4.05$-89.61
$-21.22$-4.05$-89.61

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2025-03-312024-12-312024-09-302024-03-312023-12-312023-09-30
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$34.33$0$15.86$12.03$0$6.94
$7.46$0$4.76$3.34$0$2.59
$0$0$0$0$0$0
$0$0$0$0$0$0
$-41.79$0$-20.63$-15.37$0$-9.53
$5.01$0$3.15$2.87$0$-13.32
$-36.77$0$-17.48$-12.51$0$-22.85
$0.07$0$0.00$0.00$0$0.00
$-36.85$0$-17.48$-12.51$0$-22.85
$0$0$0$0$0$0
$-36.85$0$-17.48$-12.51$0$-22.85
$0$0$0$0$0$0
$-36.85$0$-17.48$-12.51$0$-22.85
$-41.77$0$-20.63$-15.36$0$-9.53
$-41.79$0$-20.63$-15.37$0$-9.53
$-0.68$0$-1.60$-18.94$0$-38.23
$-0.68$0.00$-1.60$-18.94$0.00$-38.23